Drugmaker Moderna plans to study Canadian children during an upcoming clinical trial on its COVID-19 vaccine. The study will involve more than 67-hundred healthy children both here and in the U-S, ranging in age from just six months to 12 years old. It will evaluate the safety and effectiveness of two doses given 28 days apart and Moderna will track the children for a year after they get the second shot.
